FilingReader Intelligence
Fosun Pharma prioritizes sustainability, innovation, and shareholder value
April 23, 2025 at 05:08 PM UTC•By FilingReader AI
** Shanghai Fosun Pharmaceutical (Group) Co (HKEX:2196) has released its 2024 Environmental, Social, and Governance (ESG) and Sustainability Report, underscoring its commitment to "Innovation for Good Health". Wu Yifang, Chairman, emphasizes the company's focus on environmental protection, social responsibility, and corporate governance.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:2196•Hong Kong Exchange
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical (Group) Co publishes news
Free account required • Unsubscribe anytime